Halozyme Therapeutics Insider Sold Shares Worth $6,610,501, According to a Recent SEC Filing

MT newswire2026/10/09 07:42

03:42 AM EDT, 10/09/2026 (MT Newswires) -- Helen Torley, Director, President and Chief Executive Officer, on October 06, 2026, sold 60,000 shares in Halozyme Therapeutics (HALO) for $6,610,501. Following the Form 4 filing with the SEC, Torley has control over a total of 767,780 common shares of the company, with 767,780 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000115903626000140/xslF345X05/wk-form4_1791503775.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.